Moldovan government has established the quota for ethyl alcohol for pharmaceutical production and use in medicine in 2019 at the level of 29.8 thousand dal
In comparison with the previous year (39.13 dal), it was reduced by about 23.8%. The volumes of ethanol approved by the Cabinet for this year are intended for use in medical institutions and the pharmaceutical industry. In general, within the framework of the approved quota, 9 users will receive ethyl alcohol for medical purposes - 8 companies and the National Blood Transfusion Center. At the same time, a quota of 10.08 thousand decalitres was approved for the winners of centralized public tenders in accordance with the needs of medical and sanitary institutions (5.72 thousand dal - for Distrimed LLC and 4.36 thousand dal - for ElaDum Pharma). In general, the highest quotas of ethyl alcohol in 2019 were allocated to ElaDumPharma (formerly Farmacia Cojusna) - 13.17 thousand dal, Distrimed LLC - 5.72 thousand dal, Eurofarmaco - 4.59 thousand dal, SP RNP Pharmaceuticals - 2.86 thousand dal, Flumed-Farm - 1.2 thousand dal, Farmaco - 1.05 thousand dal. The Ministry of Health, Labor and Social Protection notes that the National Center for Blood Transfusion requested a quota for ethyl alcohol for pharmaceutical production and use in medicine this year by 37.6% more than last year, Euroopaso by 5.4% more, ElaDumPharma - by 48.8%, Farmaprim - by 7.1%, Flumed-Farm - by 53.7%. The increase in the requested quota of the last company is due to its plans to export products. At the same time, ElaDumPharma won the centralized public auction for the purchase of medicines in accordance with the needs of health facilities. At the same time, the following companies requested reduced quotas: Farmaco - by 73.8% (the company is reconstructing the enterprise and is receiving repeated permits for the production of medicines), RNP Pharmaceuticals - by 54.5% (the company did not explain the sharp decrease in the requested quotas). // 18.03.2019 - InfoMarket.